Drug manufacturer Sanofi has exempted 11 of the 16 types of health care providers eligible to participate in the 340B program from its conditions on 340B pricing for its products dispensed by contract pharmacies. However, consolidated health center programs (CH), disproportionate share hospitals (DSH), critical access hospitals (CAH), rural referral centers (RRC), and sole community hospitals (SCH) will still have to upload their 340B contract pharmacy claims data to a Sanofi vendor to keep getting 340B discounts on Sanofi products.
In an email a 340B covered entity received from Sanofi yesterday, the company said, for the first known time, “that our integrity initiative includes only” the five types of covered entities—health centers and DSH, CAH, RRC, and SCH hospitals—”that have historically accounted for a significant share of contract pharmacy dispensing, and therefore duplicate discount risk, for Sanofi’s products.”
Drug manufacturer Sanofi has exempted 11 of the 16 types of health care providers eligible to participate in the 340B program from its conditions on 340B pricing on its products dispensed by contract pharmacies. However, consolidated health center programs (CH), disproportionate share hospitals (DSH), critical access hospitals (CAH), rural referral centers (RRC), and sole community hospitals (SCH) will still have to upload their 340B contract pharmacy claims data to a Sanofi vendor to keep getting 340B discounts on Sanofi products.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.